New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

Prespecified subgroup analyses showed that primary surgery conferred greater benefits for patients with stage III disease and ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of ...

New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Cancer organizations are urging researchers, oncologists, and other stakeholders to advocate for cancer research.

An anti-inflammatory diet may be beneficial for colon cancer survivors, according to a new clinical trial. People who adhered ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...